Immunization with T cell receptor V beta chain peptides deletes pathogenic T cells and prevents the induction of collagen-induced arthritis in mice.

PubWeight™: 0.86‹?›

🔗 View Article (PMC 507379)

Published in J Clin Invest on June 15, 1996

Authors

T M Haqqi1, X M Qu, D Anthony, J Ma, M S Sy

Author Affiliations

1: Department of Medicine, Case Western Reserve University, Cleveland, OH 44106-4946, USA. txh5@cwru.edu

Articles cited by this

Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell (1988) 5.73

Prediction of immunodominant helper T cell antigenic sites from the primary sequence. J Immunol (1987) 4.95

Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell (1988) 4.47

Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science (1993) 3.30

Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature (1989) 3.00

Type II collagen autoimmunity in animals and provocations leading to arthritis. Immunol Rev (1990) 2.24

Possible role of V beta T cell receptor genes in susceptibility to collagen-induced arthritis in mice. J Exp Med (1988) 1.55

T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis. Science (1991) 1.30

A CD4 cell is capable of transferring suppression of collagen-induced arthritis. J Immunol (1989) 1.16

Restricted heterogeneity in T-cell antigen receptor V beta gene usage in the lymph nodes and arthritic joints of mice. Proc Natl Acad Sci U S A (1992) 1.12

Characterization of the T cell receptor repertoire causing collagen arthritis in mice. J Exp Med (1993) 1.12

Collagen autoimmunity and arthritis. FASEB J (1988) 1.11

T-cell receptor V beta genes repertoire in mice. Possible role in resistance and susceptibility to type II collagen-induced arthritis. J Autoimmun (1990) 1.04

Autoimmune recognition of cartilage collagens. Ann Med (1993) 0.91

T-cell receptor V region beta-chain gene expression in the autoimmune thyroiditis of non-obese diabetic mice. J Immunol (1993) 0.90

Restricted expression of T cell receptor V beta and lymphokine genes in arthritic joints of a TCR V beta a (H-2q) mouse strain-BUB/BnJ-with collagen-induced arthritis. Autoimmunity (1995) 0.88

Specific prolongation of allograft survival by a T-cell-receptor-derived peptide. Proc Natl Acad Sci U S A (1993) 0.84

CDR1 T-cell receptor beta-chain peptide induces major histocompatibility complex class II-restricted T-T cell interactions. Proc Natl Acad Sci U S A (1994) 0.84

BUB/BnJ (H-2q) is a TCR deletion mutant mouse strain (TCR V beta a, KJ16-) that is susceptible to type II collagen-induced arthritis. J Immunol (1994) 0.81

Articles by these authors

CHARMM: the biomolecular simulation program. J Comput Chem (2009) 27.71

An STS-based map of the human genome. Science (1995) 17.72

GAL4-VP16 is an unusually potent transcriptional activator. Nature (1988) 16.53

A gene map of the human genome. Science (1996) 14.32

Deletion analysis of GAL4 defines two transcriptional activating segments. Cell (1987) 14.13

A physical map of 30,000 human genes. Science (1998) 12.43

Highly pathogenic H5N1 influenza virus infection in migratory birds. Science (2005) 9.64

The genome of the social amoeba Dictyostelium discoideum. Nature (2005) 9.18

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science (1998) 6.50

A new human prostate carcinoma cell line, 22Rv1. In Vitro Cell Dev Biol Anim (1999) 4.93

Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood (1997) 4.78

Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst (1996) 4.66

Purified ryanodine receptor from rabbit skeletal muscle is the calcium-release channel of sarcoplasmic reticulum. J Gen Physiol (1988) 4.56

The carboxy-terminal 30 amino acids of GAL4 are recognized by GAL80. Cell (1987) 4.49

In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins. Blood (1996) 3.81

Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature (1997) 3.74

A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA (1996) 3.69

Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells. Blood (1997) 3.56

Active suppression of 1-fluoro-2,4-dinitrobenzene-immune T cells. Requirement of an auxiliary T cell induced by antigen. J Exp Med (1979) 3.35

Antigen- and receptor-driven regulatory mechanisms. IV. Idiotype-bearing I-J+ suppressor T cell factors induce second-order suppressor T cells which express anti-idiotypic receptors. J Exp Med (1980) 3.21

Generating yeast transcriptional activators containing no yeast protein sequences. Nature (1991) 3.21

A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J Neurosci (1999) 2.92

Quality of life (QoL) analyses from OPTIMAL (CTONG-0802), a phase III, randomised, open-label study of first-line erlotinib versus chemotherapy in patients with advanced EGFR mutation-positive non-small-cell lung cancer (NSCLC). Ann Oncol (2013) 2.92

Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine. J Cereb Blood Flow Metab (1996) 2.78

Dairy products, calcium, and prostate cancer risk in the Physicians' Health Study. Am J Clin Nutr (2001) 2.64

Large intervening non-coding RNA HOTAIR is associated with hepatocellular carcinoma progression. J Int Med Res (2011) 2.64

A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer (2005) 2.62

The superfamily of heme-copper respiratory oxidases. J Bacteriol (1994) 2.57

The role of antigen-presenting B cells in T cell priming in vivo. Studies of B cell-deficient mice. J Immunol (1988) 2.39

Joint estimation of water/fat images and field inhomogeneity map. Magn Reson Med (2008) 2.35

Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res (1999) 2.30

The B lymphocyte adhesion molecule CD22 interacts with leukocyte common antigen CD45RO on T cells and alpha 2-6 sialyltransferase, CD75, on B cells. Cell (1991) 2.24

Prevalence of cryptosporidiosis in patients undergoing endoscopy: evidence for an asymptomatic carrier state. Am J Med (1989) 2.21

An HMG-like protein that can switch a transcriptional activator to a repressor. Nature (1994) 2.18

Surveillance of the first case of human avian influenza A (H7N9) virus in Beijing, China. Infection (2013) 2.18

Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor. Science (1992) 2.12

Smoking cessation in China: findings from the 1996 national prevalence survey. Tob Control (2001) 2.10

Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis (1999) 2.06

A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy. EMBO J (1999) 1.96

FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome. Nat Genet (1998) 1.96

Characterization of short tandem repeats from thirty-one human telomeres. Genome Res (1997) 1.96

Immune suppression with supraoptimal doses of antigen in contact sensitivity. I. Demonstration of suppressor cells and their sensitivity to cyclophosphamide. J Immunol (1977) 1.87

A splenic requirement for the generation of suppressor T cells. J Immunol (1977) 1.86

An allosteric model of the molecular interactions of excitation-contraction coupling in skeletal muscle. J Gen Physiol (1993) 1.83

TSF3, a global regulatory protein that silences transcription of yeast GAL genes, also mediates repression by alpha 2 repressor and is identical to SIN4. Mol Cell Biol (1993) 1.82

Prion protein expression in different species: analysis with a panel of new mAbs. Proc Natl Acad Sci U S A (1998) 1.80

A colon cancer cell line (LIM1215) derived from a patient with inherited nonpolyposis colorectal cancer. J Natl Cancer Inst (1985) 1.79

Printable thin film supercapacitors using single-walled carbon nanotubes. Nano Lett (2009) 1.79

Mitochondrial depolarization accompanies cytochrome c release during apoptosis in PC6 cells. J Biol Chem (1999) 1.75

Prostate cancer incidence and mortality in the United States and the United Kingdom. J Natl Cancer Inst (1998) 1.74

Impairment of antigen-presenting cell function by ultraviolet radiation. Proc Natl Acad Sci U S A (1979) 1.73

Suppressive mechanisms involving sensitization and tolerance in contact allergy. Immunol Rev (1980) 1.72

Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Stroke (1994) 1.71

High prevalence of bla(CTX-M) extended-spectrum β-lactamase genes in Escherichia coli isolates from pets and emergence of CTX-M-64 in China. Clin Microbiol Infect (2010) 1.70

The induction of hapten-specific T cell tolerance using hapten-modified lymphoid membranes. II. Relative roles of suppressor T cells and clone inhibition in the tolerant state. Eur J Immunol (1977) 1.66

Human ZIP1 is a major zinc uptake transporter for the accumulation of zinc in prostate cells. J Inorg Biochem (2003) 1.66

Antigen- and receptor-driven regulatory mechanisms. I. Induction of suppressor T cells with anti-idiotypic antibodies. J Exp Med (1979) 1.62

T cell development in B cell-deficient mice. IV. The role of B cells as antigen-presenting cells in vivo. J Immunol (1986) 1.62

Absence of protease-resistant prion protein in the cerebrospinal fluid of Creutzfeldt-Jakob disease. J Pathol (2001) 1.61

Alzheimer presenilins in the nuclear membrane, interphase kinetochores, and centrosomes suggest a role in chromosome segregation. Cell (1997) 1.60

The Drosophila morphogenetic protein Bicoid binds DNA cooperatively. Development (1996) 1.59

Career characteristics of graduates of a Medical Scientist Training Program, 1970-1990. Acad Med (1996) 1.58

Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization. FEBS Lett (2001) 1.58

Drilling the posterior wall of the petrous pyramid: a microneurosurgical anatomical study. J Neurosurg (1993) 1.57

Developmental regulation of heterochromatin-mediated gene silencing in Drosophila. Development (1998) 1.56

Functional calcium release channel formed by the carboxyl-terminal portion of ryanodine receptor. Biophys J (1997) 1.55

MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma. Oncogene (2012) 1.55

Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men. Mol Cell (1999) 1.54

Opposing regulatory functions of positive and negative elements in UASG control transcription of the yeast GAL genes. Mol Cell Biol (1990) 1.53

Novel promoter polymorphism in insulin-like growth factor-binding protein-3: correlation with serum levels and interaction with known regulators. J Clin Endocrinol Metab (2001) 1.53

Beta-carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinoma. Cancer (1999) 1.50

Efficient assessment of neuropathic pain drugs in patients with small fiber sensory neuropathies. Pain (2008) 1.49

Insight into the active-site structure and function of cytochrome oxidase by analysis of site-directed mutants of bacterial cytochrome aa3 and cytochrome bo. J Bioenerg Biomembr (1993) 1.49

Expression of hyaluronidase by tumor cells induces angiogenesis in vivo. Proc Natl Acad Sci U S A (1996) 1.49

Antigen- and receptor-driven regulatory mechanisms. III. Induction of delayed type hypersensitivity to azobenzenearsonate with anti-cross-reactive idiotypic antibodies. J Exp Med (1980) 1.48

The missing link between thermodynamics and structure in F1-ATPase. Proc Natl Acad Sci U S A (2003) 1.48

The asp-rich region at the carboxyl-terminus of calsequestrin binds to Ca(2+) and interacts with triadin. FEBS Lett (2000) 1.48

INFORMAS (International Network for Food and Obesity/non-communicable diseases Research, Monitoring and Action Support): overview and key principles. Obes Rev (2013) 1.46

Giant anharmonic phonon scattering in PbTe. Nat Mater (2011) 1.45

Identification of an epitope in the C terminus of normal prion protein whose expression is modulated by binding events in the N terminus. J Mol Biol (2000) 1.44

The winged helix/forkhead transcription factor Foxq1 regulates differentiation of hair in satin mice. Genesis (2001) 1.44

Antigen- and receptor-driven regulatory mechanisms. VIII. Suppression of idiotype-negative, p-azobenzenearsonate-specific T cells results from the interaction of an anti-idiotypic second-order T suppressor cell with a cross-reactive-idiotype-positive, p-azobenzenearsonate-primed T cell target. J Exp Med (1981) 1.42

Systematic review and meta-analysis of the association between P53 codon 72 polymorphism and colorectal cancer. Eur J Surg Oncol (2010) 1.42

Antigen- and receptor-driven regulatory mechanisms. II. Induction of suppressor T cells with idiotype-coupled syngeneic spleen cells. J Exp Med (1979) 1.42

Cancellous bone volume and structure in the forearm: noninvasive assessment with MR microimaging and image processing. Radiology (1998) 1.42

Association between carcinogen-DNA adducts in white blood cells and lung cancer risk in the physicians health study. Cancer Res (2001) 1.40

Rescue of bicoid mutant Drosophila embryos by bicoid fusion proteins containing heterologous activating sequences. Nature (1989) 1.40

Drosophila ELL is associated with actively elongating RNA polymerase II on transcriptionally active sites in vivo. EMBO J (2001) 1.39

Local Thermal Fixing of a Photorefractive LiNbO(3) Hologram by use of a CO(2) Laser. Appl Opt (1998) 1.39

Supplemental vitamin E intake and prostate cancer risk in a large cohort of men in the United States. Cancer Epidemiol Biomarkers Prev (1999) 1.37

Circulating vitamin D metabolites in relation to subsequent development of prostate cancer. Cancer Epidemiol Biomarkers Prev (1996) 1.36

No strict alignment is required between a transcriptional activator binding site and the "TATA box" of a yeast gene. Proc Natl Acad Sci U S A (1988) 1.35

Virulence properties and protective efficacy of the capsular polymer of Haemophilus (Actinobacillus) pleuropneumoniae serotype 5. Infect Immun (1988) 1.35

Human mdm2 mediates multiple mono-ubiquitination of p53 by a mechanism requiring enzyme isomerization. J Biol Chem (2001) 1.35

Liraglutide provides similar glycaemic control as glimepiride (both in combination with metformin) and reduces body weight and systolic blood pressure in Asian population with type 2 diabetes from China, South Korea and India: a 16-week, randomized, double-blind, active control trial(*). Diabetes Obes Metab (2011) 1.33

Heritable alteration in DNA methylation induced by nitrogen-deficiency stress accompanies enhanced tolerance by progenies to the stress in rice (Oryza sativa L.). J Plant Physiol (2011) 1.33

Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer. Cancer Res (1994) 1.33

The organic component of diesel exhaust particles and phenanthrene, a major polyaromatic hydrocarbon constituent, enhances IgE production by IgE-secreting EBV-transformed human B cells in vitro. Toxicol Appl Pharmacol (1997) 1.33

Aberrant metal binding by prion protein in human prion disease. J Neurochem (2001) 1.33